Add BrightSurf on Google Email

PolyU develops AI-powered virtual patient simulation system integrating multimodal data to advance personalized cancer treatment

The PolyU developed AI Virtual Patient Simulation System combines multimodal data from genomic, medical imaging and clinical records to create a digital twin model tracking real-time changes in a patient's condition. It predicts the effectiveness of different cancer treatment options and supports personalized medical solutions.

SourceThe Hong Kong Polytechnic University·JournalMedical Image Analysis·DateAug 14, 2026

The Journal of Nuclear Medicine ahead-of-print tip sheet: August 14, 2026

Research published in The Journal of Nuclear Medicine highlights the importance of intermediate amyloid PET uptake in Alzheimer's disease diagnosis and its association with cognitive decline. Additionally, studies show promising results for early SPECT/CT response prediction in PSMA-positive prostate cancer treatment, as well as potent...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateAug 14, 2026

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 11, 2026

New research articles published in The Journal of Nuclear Medicine explore intensified PSMA-targeted therapy for advanced prostate cancer, as well as novel approaches to targeted radiopharmaceutical therapy. Studies also investigate radiation doses from PSMA-targeted therapy and their relationship with treatment outcomes, while others ...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateAug 11, 2026

Three-dimensional visualization of nanoplastic distribution in the neonatal mouse brain

A new method for three-dimensional visualization of nanoplastic distribution in the neonatal mouse brain has been established, revealing particle-size-dependent biodistribution patterns. The study found that smaller particles (50 nm) were widely distributed throughout the brain, while larger particles (500 nm) showed weaker accumulation.

SourceNational Institute for Environmental Studies·JournalJournal of Hazardous Materials Advances·TypeExperimental study·DateJul 29, 2026

Brain metabolism predicts survival in advanced non–small cell lung cancer patients

Researchers found that high brain metabolism is associated with longer overall survival, and it's an independent prognostic factor for overall survival. Brain metabolism measured by ¹⁸F-FDG PET/CT provides valuable insight into patient outcomes and may help identify patients most likely to benefit from early supportive care.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJul 24, 2026

The Journal of Nuclear Medicine ahead-of-print tip sheet: July 23, 2026

A new study published in The Journal of Nuclear Medicine has found that dual-energy SPECT may enable faster monitoring of PSMA therapy, reducing imaging time from 18 minutes to 9 minutes. Another study showed a prognostic model using PSMA PET can predict outcomes after therapy, including overall survival and PSA progression-free survival.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJul 24, 2026

A Chinese neurosurgical journal’s study identifies a risk factor for post-surgical stroke in moyamoya disease

A Chinese neurosurgical journal's study found that severe stenosis of major intracranial arteries increases the risk of cerebral infarction after revascularization surgery in moyamoya disease. Severe blockage was associated with postoperative infarctions, highlighting the importance of monitoring and mitigating this risk factor.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateJul 20, 2026

The Journal of Nuclear Medicine ahead-of-print tip sheet: July 17, 2026

Researchers have made significant breakthroughs in targeted radiation therapy for pancreatic cancer, PARP inhibitor treatment, and Alzheimer's disease detection. New PET-based scores may predict prostate cancer outcomes, while blood cell mutations are associated with side effects in advanced prostate cancer patients.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJul 17, 2026

Kilometer-scale high-resolution fast non-line-of-sight imaging achieved by laser reflective tomography

Researchers have introduced laser reflective tomography to overcome the speed-resolution trade-off in NLOS imaging, achieving kilometer-scale high-resolution imaging without scanning mechanisms. This innovative approach combines single-point detection with multi-angle projection data for accurate scene reconstruction.

SourceEditorial Office of Opto-Electronic Journals Group·JournalOpto-Electronic Science·TypeExperimental study·DateJun 26, 2026

Mary Beth Farrell receives 2026 SNMMI-TS Lifetime Achievement Award for transformative contributions to nuclear medicine technology

Mary Beth Farrell has been honored with the 2026 SNMMI-TS Lifetime Achievement Award for her decades-long dedication to elevating the nuclear medicine profession. Her leadership in accreditation, research, and education has shaped national standards and driven quality improvement initiatives that continue to impact patient care.

New scenarios for photonic computing: a new era of photonic AI for medical diagnosis

Researchers developed a black phosphorus-based all-fiber photonic artificial intelligence diagnostic platform, achieving 246-fold energy efficiency gains. The system achieved 95.0% accuracy in retinal detachment detection and 97.6% specificity in hepatocellular carcinoma diagnosis.

SourceEditorial Office of Opto-Electronic Journals Group·JournalOpto-Electronic Advances·TypeExperimental study·DateJun 17, 2026

FAP-targeted radiopharmaceutical therapy shows broad effectiveness across multiple cancers

A novel FAP-targeted radiopharmaceutical therapy approach has shown safety and effectiveness in treating various types of cancer, including breast, colorectal, gastric, and ovarian cancers. The treatment achieved objective responses in approximately two-thirds of patients and disease control in over 80%.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 17, 2026

Could MRI predict kidney disease before it develops? Award-winning study suggests new possibilities

Researchers used advanced MRI techniques to evaluate kidney blood flow, oxygen utilization, and inflammation in patients undergoing surgery for kidney tumors. The study found that MRI measurements could help predict both kidney function decline and the future development of chronic kidney disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Magnetic Resonance Imaging·TypeImaging analysis·DateJun 9, 2026

FireANTs brings AI speed and geometric precision to medical imaging

FireANTs, an open-source algorithm, combines AI optimization and geometry to quickly match complex medical images. The new method can accomplish what took weeks in minutes, detecting subtle changes that signal disease or cognitive decline, making it practical for clinical practice.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Communications·TypeData/statistical analysis·DateJun 9, 2026

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: June 5, 2026

The Journal of Nuclear Medicine has published several groundbreaking studies on targeted radiotherapy approaches for various types of cancer. Researchers have successfully identified tumors using fibroblast activation protein (FAP)-targeting compounds and explored the potential of PET/MRI scans in detecting endometriosis and recurrent ...

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 5, 2026

Seven-second X-ray scan accurately detects severity of heart valve regurgitation in patients with repaired congenital heart defects

A simple, seven-second X-ray scan can accurately detect the severity of pulmonary valve regurgitation in patients with repaired Tetralogy of Fallot. The test uses dynamic chest radiography and requires minimal radiation, offering a more accessible diagnostic option for those who cannot undergo traditional methods.

SourceKyushu University·JournalRadiology·TypeExperimental study·DateJun 4, 2026

PET imaging reveals synaptic loss in multiple sclerosis across preclinical and human studies

A new PET imaging approach measures synaptic density in the spinal cord, allowing physicians to monitor disease progression and evaluate treatment effectiveness. This technique detects widespread reductions in synaptic connections across the brain and spinal cord in patients with multiple sclerosis.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 2, 2026

Gary Ulaner, MD, Ph.D., elected president-elect of the Society of Nuclear Medicine and Molecular Imaging

Gary Ulaner, a renowned nuclear medicine expert, has been elected president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He aims to advance SNMMI's Mars Shot initiative, expand educational activities for professionals, and increase funding for training new radiochemistry and physics specialists.

Innovative bedside PET scanner enables real-time imaging for interventional procedures

A newly developed portable point-of-care PET technology provides high-quality results for guiding biopsies, tumor ablations, and other interventional procedures. The bedside device offers real-time visual feedback, making it a cost-effective approach for hospitals to perform procedures in constrained clinical environments.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 1, 2026

Recent advances in the diagnosis and treatment of fat accumulation in liver and pancreas

Researchers highlight latest developments in pathology, diagnosis, and treatment of MASLD and IPFD, revealing correlations with chronic diseases like liver cancer and pancreatic cancer. Innovative treatments, such as AI-driven approaches and organ-targeted therapies, show promise for precision prevention and therapy.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeSystematic review·DateJun 1, 2026

Next-generation PET tracer enables rapid, high-precision detection of kidney cancer

A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background contrast in detecting clear cell renal cell carcinoma (ccRCC). The tracer successfully identified additional metastatic lesions missed by standard imaging while reducing abdominal background noise.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 1, 2026

Martin G. Pomper, MD, Ph.D., receives 2026 Benedict Cassen Prize for Outstanding Contributions to Nuclear Medicine

Dr. Martin G. Pomper has been awarded the 2026 Benedict Cassen Prize for his outstanding contributions to nuclear medicine, particularly in the development of PSMA-targeted agents. His work has led to significant advances in cancer diagnosis and treatment, including the creation of commercial PSMA-targeted PET agents.